Dr Agarwal’s Healthcare IPO Day 2 Live Updates: Issue booked 7% so far. Check latest GMP, subscription status, review
₹875.5 crore from anchor investors.The ₹3,027.26-crore Dr Agarwal IPO, with a price band of ₹382 to ₹402 per share, will conclude on January 31.Dr Agarwal Healthcare IPO consists of a new issue of up to ₹300 crore along with an Offer For Sale (OFS) of up to 6.78 crore equity shares valued at ₹2,727.26 crore if priced at the highest point of the price range. Shareholders participating in the OFS include Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.
The funds raised from the new issue, approximately ₹195 crore, will be allocated for debt repayment. Additionally, a portion of the funds will be directed towards general corporate needs and unspecified acquisitions.Dr Agarwal's Health Care offers a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.As of September 2024, the network included 193 facilities, primarily located in South India, especially in Chennai, Hyderabad, and Bengaluru, with a significant presence also in Western India.Stay tuned for more updatesPrior to its initial offering to the public (IPO), Dr.
Read more on livemint.com
